Seres Therapeutics Inc (MCRB) — Net Asset Quality Index
Seres Therapeutics Inc (MCRB) has a Net Asset Quality Index of 34.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $101.59 Million minus total liabilities of $67.05 Million yields net assets of $34.53 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Seres Therapeutics Inc (MCRB) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Seres Therapeutics Inc Net Asset Quality Index Over Time (2012–2025)
This chart shows how Seres Therapeutics Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 34.0%, representing net assets of $34.53 Million against total assets of $101.59 Million USD. For live market cap and overall valuation, see how much is Seres Therapeutics Inc worth.
Annual Net Asset Quality Index for Seres Therapeutics Inc (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Seres Therapeutics Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check MCRB PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 32.0% | $44.22 Million | $138.19 Million | $93.97 Million | ▲ +22.1 pp |
| 2024 | 9.9% | $13.78 Million | $139.81 Million | $126.03 Million | ▲ +22.4 pp |
| 2023 | -12.5% | $-44.86 Million | $358.60 Million | $403.46 Million | ▼ -15.6 pp |
| 2022 | 3.1% | $10.78 Million | $348.78 Million | $338.00 Million | ▼ -34.0 pp |
| 2021 | 37.1% | $131.51 Million | $354.86 Million | $223.35 Million | ▼ -13.9 pp |
| 2020 | 51.0% | $174.75 Million | $342.94 Million | $168.19 Million | ▲ +87.4 pp |
| 2019 | -36.5% | $-48.32 Million | $132.44 Million | $180.76 Million | ▲ +3.4 pp |
| 2018 | -39.9% | $-48.05 Million | $120.47 Million | $168.52 Million | ▼ -71.9 pp |
| 2017 | 32.0% | $60.70 Million | $189.52 Million | $128.82 Million | ▼ -16.6 pp |
| 2016 | 48.6% | $132.63 Million | $272.65 Million | $140.01 Million | ▼ -46.0 pp |
| 2015 | 94.7% | $205.39 Million | $216.90 Million | $11.51 Million | ▲ +117.5 pp |
| 2014 | -22.8% | $-26.72 Million | $117.34 Million | $144.07 Million | ▼ -52.5 pp |
| 2013 | 29.7% | $631.00K | $2.12 Million | $1.49 Million | ▼ -67.6 pp |
| 2012 | 97.3% | $6.36 Million | $6.54 Million | $178.00K | — |